Cutis gyrata-acanthosis nigricans-craniosynostosis syndrome

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:1555OMIM:123790Q87.8
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Cutis gyrata-acanthosis nigricans-craniosynostosis syndrome (also known as Beare-Stevenson cutis gyrata syndrome) is an extremely rare genetic disorder characterized by the triad of cutis gyrata (furrowed, thickened skin with a corrugated appearance), acanthosis nigricans (dark, velvety thickening of the skin, particularly in body folds), and craniosynostosis (premature fusion of the skull bones). The condition is caused by gain-of-function mutations in the FGFR2 (fibroblast growth factor receptor 2) gene. Affected individuals typically present at birth with a distinctive craniofacial appearance including a cloverleaf skull deformity (Kleeblattschädel) or other forms of craniosynostosis, midface hypoplasia, prominent eyes, and ear anomalies. The widespread skin abnormalities, particularly the deeply furrowed cutis gyrata pattern, are a hallmark feature that distinguishes this condition from other FGFR2-related craniosynostosis syndromes. The syndrome affects multiple body systems, including the skeletal system (craniosynostosis, digital anomalies), the integumentary system (cutis gyrata, acanthosis nigricans, skin tags), and the craniofacial structures. Additional features may include anogenital anomalies, a prominent umbilical stump, and developmental delay. The prognosis is generally poor, with many affected individuals experiencing significant morbidity and early mortality, often related to respiratory complications or neurological compromise from increased intracranial pressure. Management is supportive and multidisciplinary, involving neurosurgical intervention for craniosynostosis to relieve intracranial pressure, craniofacial reconstruction, and dermatologic care. There is no cure for the underlying genetic condition, and treatment focuses on addressing individual symptoms and complications as they arise.

Also known as:

Clinical phenotype terms— hover any for plain English:

Thickened helicesHP:0000391
Inheritance

Autosomal dominant

Passed on from just one parent; each child has about a 50% chance of inheriting it

Age of Onset

Neonatal

Begins at or shortly after birth (first 4 weeks)

Orphanet ↗OMIM ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Cutis gyrata-acanthosis nigricans-craniosynostosis syndrome.

View clinical trials →

No actively recruiting trials found for Cutis gyrata-acanthosis nigricans-craniosynostosis syndrome at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Cutis gyrata-acanthosis nigricans-craniosynostosis syndrome community →

No specialists are currently listed for Cutis gyrata-acanthosis nigricans-craniosynostosis syndrome.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Cutis gyrata-acanthosis nigricans-craniosynostosis syndrome.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Cutis gyrata-acanthosis nigricans-craniosynostosis syndromeForum →

No community posts yet. Be the first to share your experience with Cutis gyrata-acanthosis nigricans-craniosynostosis syndrome.

Start the conversation →

Latest news about Cutis gyrata-acanthosis nigricans-craniosynostosis syndrome

No recent news articles for Cutis gyrata-acanthosis nigricans-craniosynostosis syndrome.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Cutis gyrata-acanthosis nigricans-craniosynostosis syndrome

What is Cutis gyrata-acanthosis nigricans-craniosynostosis syndrome?

Cutis gyrata-acanthosis nigricans-craniosynostosis syndrome (also known as Beare-Stevenson cutis gyrata syndrome) is an extremely rare genetic disorder characterized by the triad of cutis gyrata (furrowed, thickened skin with a corrugated appearance), acanthosis nigricans (dark, velvety thickening of the skin, particularly in body folds), and craniosynostosis (premature fusion of the skull bones). The condition is caused by gain-of-function mutations in the FGFR2 (fibroblast growth factor receptor 2) gene. Affected individuals typically present at birth with a distinctive craniofacial appearan

How is Cutis gyrata-acanthosis nigricans-craniosynostosis syndrome inherited?

Cutis gyrata-acanthosis nigricans-craniosynostosis syndrome follows a autosomal dominant inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does Cutis gyrata-acanthosis nigricans-craniosynostosis syndrome typically begin?

Typical onset of Cutis gyrata-acanthosis nigricans-craniosynostosis syndrome is neonatal. Age of onset can vary across affected individuals.